PURETHAL Grasses Rush Study
NCT01059266
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
150
Enrollment
INDUSTRY
Sponsor class
Conditions
Allergic Rhinitis
Allergic Rhinoconjunctivitis
Interventions
DRUG:
PURETHAL Grasses, 20.000 AUM/ml
Sponsor
HAL Allergy